2014 Q1 Form 10-Q Financial Statement

#000114420414015093 Filed on March 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q2 2013 Q1
Revenue $0.00 $1.629M $0.00
YoY Change
Cost Of Revenue $252.4K
YoY Change
Gross Profit $1.376M
YoY Change
Gross Profit Margin 84.5%
Selling, General & Admin $638.0K
YoY Change
% of Gross Profit 46.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $47.83K
YoY Change
% of Gross Profit 3.48%
Operating Expenses $854.7K $1.132M $470.3K
YoY Change 81.74%
Operating Profit -$854.7K $244.6K -$470.3K
YoY Change 81.74%
Interest Expense $7.562K $0.00 $4.537K
YoY Change 66.67%
% of Operating Profit 0.0%
Other Income/Expense, Net -$7.562K $0.00 -$4.537K
YoY Change 66.67%
Pretax Income -$862.3K $244.6K -$474.9K
YoY Change 81.59%
Income Tax $0.00 $61.93K $0.00
% Of Pretax Income 25.32%
Net Earnings -$862.3K $91.32K -$474.9K
YoY Change 81.59%
Net Earnings / Revenue 5.61%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 8.895M shares 6.755M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q2 2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $67.25K
Prepaid Expenses
Receivables $148.5K
Other Receivables
Total Short-Term Assets $1.550M $65.90K
YoY Change -39.93%
LONG-TERM ASSETS
Property, Plant & Equipment $1.163M $4.486K
YoY Change -20.77%
Goodwill
YoY Change
Intangibles $11.54K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.174M $4.486K
YoY Change -20.77%
TOTAL ASSETS
Total Short-Term Assets $1.550M $65.90K
Total Long-Term Assets $1.174M $4.486K
Total Assets $2.724M $70.38K
YoY Change -38.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $574.8K $72.04K
YoY Change 540.81%
Accrued Expenses $0.00 $17.41K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.180M $424.6K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.267M $527.8K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.180M $424.6K
Total Long-Term Liabilities $1.267M $527.8K
Total Liabilities $2.448M $952.4K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $160.0K
YoY Change
Common Stock $3.216M $1.392M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $138.2K -$882.0K
YoY Change
Total Liabilities & Shareholders Equity $2.724M $70.38K
YoY Change

Cashflow Statement

Concept 2014 Q1 2013 Q2 2013 Q1
OPERATING ACTIVITIES
Net Income -$862.3K $91.32K -$474.9K
YoY Change 81.59%
Depreciation, Depletion And Amortization $47.83K
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $4.862K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures $4.862K
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-11424 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3939 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
285868 USD
CY2014Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
38675 USD
CY2014Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
500000 USD
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
42 USD
CY2014Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11776 USD
CY2014Q1 us-gaap Liabilities
Liabilities
1614145 USD
CY2014Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
7847 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3186568 USD
CY2014Q1 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
4147982 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
-953567 USD
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
660578 USD
us-gaap Fiscal Period
FiscalPeriod
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><u><font style="FONT-SIZE: 10pt">Fiscal Year End</font></u></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company elected April 30th as its fiscal year ending date.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><u><font style="FONT-SIZE: 10pt">Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions</font></u></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt"><font style="TEXT-DECORATION: none">&#160;</font></font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the reported amounts of revenues and expenses during the reporting period(s).</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. The Company&#8217;s critical accounting estimates and assumptions affecting the financial statements were:</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"></td> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="COLOR: black; FONT-SIZE: 10pt">(i)</font></div> </td> <td style="TEXT-ALIGN: justify; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><i><font style="FONT-SIZE: 10pt">Assumption as a going concern:</font></i> <font style="FONT-SIZE: 10pt">Management assumes that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business;</font></div> </td> </tr> </table> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"></td> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="COLOR: black; FONT-SIZE: 10pt">(ii)</font></div> </td> <td style="TEXT-ALIGN: justify; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><i><font style="FONT-SIZE: 10pt">Fair value of long-lived assets:</font></i> <font style="FONT-SIZE: 10pt">Fair value is generally determined using the asset&#8217;s expected future discounted cash flows or market value, if readily determinable.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives. The Company considers the following to be some examples of important indicators that may trigger an impairment review: (i)&#160;significant under-performance or losses of assets relative to expected historical or projected future operating results; (ii)&#160;significant changes in the manner or use of assets or in the Company&#8217;s overall strategy with respect to the manner or use of the acquired assets or changes in the Company&#8217;s overall business strategy; (iii)&#160;significant negative industry or economic trends; (iv)&#160;increased competitive pressures; (v)&#160;a significant decline in the Company&#8217;s stock price for a sustained period of time; and (vi)&#160;regulatory changes.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The Company evaluates acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events;</font></div> </td> </tr> </table> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"></td> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="COLOR: black; FONT-SIZE: 10pt">(iii)</font></div> </td> <td style="TEXT-ALIGN: justify; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><i><font style="FONT-SIZE: 10pt">Valuation allowance for deferred tax assets:</font></i> <font style="FONT-SIZE: 10pt"> Management assumes that the realization of the Company&#8217;s net deferred tax assets resulting from its net operating loss (&#8220;NOL&#8221;) carry&#150;forwards for Federal income tax purposes that may be offset against future taxable income was not considered more likely than not and accordingly, the potential tax benefits of the net loss carry-forwards are offset by a full valuation allowance. Management made this assumption based on (a) the Company has incurred recurring losses, (b) general economic conditions, and (c) its ability to raise additional funds to support its daily operations by way of a public or private offering, among other factors;</font></div> </td> </tr> </table> <table style="MARGIN-TOP: 0pt; FONT-FAMILY: Times New Roman; MARGIN-BOTTOM: 0pt; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; VERTICAL-ALIGN: top; PADDING-TOP: 0in"> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"></td> <td style="WIDTH: 0.25in; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><font style="COLOR: black; FONT-SIZE: 10pt">(iv)</font></div> </td> <td style="TEXT-ALIGN: justify; WORD-WRAP: break-word; VERTICAL-ALIGN: top"> <div><i><font style="FONT-SIZE: 10pt">Estimates and assumptions used in valuation of equity instruments:</font></i> <font style="FONT-SIZE: 10pt">Management estimates expected term of share options and similar instruments, expected volatility of the Company&#8217;s common shares and the method used to estimate it, expected annual rate of quarterly dividends, and risk free rate(s) to value share options and similar instruments.</font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Actual results could differ from those estimates.</font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014Q1 us-gaap Cash
Cash
350158 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
154878 USD
CY2014Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
150000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
655036 USD
CY2014Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8018 USD
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2476 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5542 USD
CY2014Q1 us-gaap Assets
Assets
660578 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1375000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1125000 shares
ltnr Description Of Nature Of Ownership Change
DescriptionOfNatureOfOwnershipChange
In general terms, an ownership change may result from transactions increasing the ownership of certain stockholders in the stock of a corporation by more than 50 percentage points over a three-year period.
us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement.
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2377 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1108 USD
CY2013Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
100000 USD
CY2013Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
50000 USD
CY2013Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2013Q3 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.06 pure
CY2013Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2015-03-25
CY2013Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2015-09-17
CY2013Q2 ltnr Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
100000 USD
CY2013Q4 ltnr Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
50000 USD
CY2014Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2014Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7847083 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6265000 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7847083 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6265000 shares
ltnr Service Management Costs On Quarterly Basis
ServiceManagementCostsOnQuarterlyBasis
270000 USD
ltnr Service Management Costs On Quarterly Basis
ServiceManagementCostsOnQuarterlyBasis
270000 USD
ltnr Service Management Costs Long Term
ServiceManagementCostsLongTerm
250002 USD
ltnr Service Management Costs Long Term
ServiceManagementCostsLongTerm
250002 USD
ltnr Amortization Of Fair Value Of Warrant Issued
AmortizationOfFairValueOfWarrantIssued
20646 USD
ltnr Amortization Of Fair Value Of Warrant Issued
AmortizationOfFairValueOfWarrantIssued
20646 USD
us-gaap Service Management Costs
ServiceManagementCosts
540648 USD
us-gaap Service Management Costs
ServiceManagementCosts
540648 USD
CY2011Q3 ltnr Service Management Period
ServiceManagementPeriod
P3Y
CY2011Q3 ltnr Service Management Expired Date
ServiceManagementExpiredDate
2014-09-22
CY2011Q3 ltnr Service Management Cost Description
ServiceManagementCostDescription
Under the Management Agreement the Company will compensate Trinad LLC for its services with (i) a fee equal to $2,080,000, with $90,000 payable in advance of each consecutive three-month calendar period during the term of the Agreement and with $1,000,000 due at the end of the three (3) year term unless the Management Agreement is otherwise terminated earlier in accordance with its terms
CY2011Q3 ltnr Warrants Granted Fair Value
WarrantsGrantedFairValue
82575 USD
CY2011Q3 ltnr Amortized Period For Warrants Granted
AmortizedPeriodForWarrantsGranted
P3Y
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1125000 shares
CY2011Q3 ltnr Warrants Exercise Price
WarrantsExercisePrice
0.15
CY2011Q3 ltnr Management Services Payment Description
ManagementServicesPaymentDescription
The Company (i)(a) recorded $30,000 per month for the $1,080,000 portion of the management services to be paid on a quarterly basis, accrued (i)(b) $27,778 per month for the $1,000,000 portion of the management services, due at the end of the three (3) year term; and (ii) recorded amortization of $2,294 per month for the fair value of the warrant portion of the management services issued on September 23, 2011 in connection with the Management Agreement, or $60,072 of management services per month in aggregate.
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1125000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
ltnr Stock Issued During Period Shares Stock Options Exercised Cashless
StockIssuedDuringPeriodSharesStockOptionsExercisedCashless
0 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1125000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
875000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
250000 shares
ltnr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Granted Options Weighted Average Exercise Price1
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeGrantedOptionsWeightedAverageExercisePrice1
0
ltnr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Forfeiture Options Weighted Average Exercise Price1
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeForfeitureOptionsWeightedAverageExercisePrice1
0
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.15
ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Granted Options Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsGrantedOptionsOutstanding
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Options Forfeiture
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsOptionsForfeiture
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Options Exercisable Cash Less
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsOptionsExercisableCashLess
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Options Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsOptionsExercisable
0 USD
ltnr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Cashless Price1
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExerciseCashlessPrice1
0
ltnr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercised Options Weighted Average Exercise Price1
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisedOptionsWeightedAverageExercisePrice1
0
ltnr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Expired Options Weighted Average Exercise Price1
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExpiredOptionsWeightedAverageExercisePrice1
0
CY2014Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.15
CY2014Q1 ltnr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Earned And Exercisable Options Weighted Average Exercise Price1
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeEarnedAndExercisableOptionsWeightedAverageExercisePrice1
0.15
CY2014Q1 ltnr Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Non Vested Options Weighted Average Exercise Price1
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNonVestedOptionsWeightedAverageExercisePrice1
0.15
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
ltnr Share Based Compensation Arrangements By Share Basedpayment Award Options Exercises In Period Weighted Average Exercise Cash Less Price
ShareBasedCompensationArrangementsByShareBasedpaymentAwardOptionsExercisesInPeriodWeightedAverageExerciseCashLessPrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.15
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.15
ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Options Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsOptionsExpired
0 USD
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Options Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsOptionsOutstanding
82575 USD
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Options Earned And Exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsOptionsEarnedAndExercisable
64232 USD
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Fair Value Nonvested Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueNonvestedOptions
18343 USD
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedIntrinsicValue
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Forfeiture For Cash Less Exercise Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitureForCashLessExerciseIntrinsicValue
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Cash Less Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableCashLessIntrinsicValue
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue
0 USD
ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageIntrinsicValue
0 USD
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue
0 USD
CY2014Q1 ltnr Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price One
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceOne
0.15
CY2014Q1 ltnr Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Two
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceTwo
0.15
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberOne
1125000 shares
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Two
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberTwo
1125000 shares
ltnr Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term One
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermOne
P7Y7M24D
ltnr Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term Two
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermTwo
P7Y7M24D
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceOne
0.15
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Two
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceTwo
0.15
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberOne
1125000 shares
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Two
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberTwo
1125000 shares
ltnr Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term One
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermOne
P7Y7M24D
ltnr Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term Two
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermTwo
P7Y7M24D
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price One
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceOne
0.15
CY2014Q1 ltnr Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Two
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceTwo
0.15
CY2012Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
200000 shares
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
50000 USD
CY2013Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
250000 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2013Q1 us-gaap Revenues
Revenues
0 USD
CY2014Q1 us-gaap Revenues
Revenues
0 USD
ltnr Consulting Fees
ConsultingFees
295490 USD
ltnr Consulting Fees
ConsultingFees
627003 USD
CY2013Q1 ltnr Consulting Fees
ConsultingFees
242180 USD
CY2013Q1 us-gaap Service Management Costs
ServiceManagementCosts
180216 USD
CY2014Q1 us-gaap Service Management Costs
ServiceManagementCosts
180216 USD
us-gaap Professional Fees
ProfessionalFees
326522 USD
CY2013Q1 us-gaap Professional Fees
ProfessionalFees
6387 USD
CY2014Q1 us-gaap Professional Fees
ProfessionalFees
180342 USD
ltnr Payroll Expenses
PayrollExpenses
0 USD
ltnr Payroll Expenses
PayrollExpenses
68010 USD
CY2013Q1 ltnr Payroll Expenses
PayrollExpenses
0 USD
CY2014Q1 ltnr Payroll Expenses
PayrollExpenses
25967 USD
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
76432 USD
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
108601 USD
CY2013Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
41963 USD
CY2014Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
47392 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4944 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
132237 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
-421 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34082 USD
us-gaap Operating Expenses
OperatingExpenses
980140 USD
us-gaap Operating Expenses
OperatingExpenses
1803021 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
470325 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
854749 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-980140 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1803021 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-470325 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-854749 USD
ltnr Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
0 USD
ltnr Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
50000 USD
CY2013Q1 ltnr Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
0 USD
CY2014Q1 ltnr Impairment Of Notes Receivable
ImpairmentOfNotesReceivable
0 USD
us-gaap Interest Expense
InterestExpense
13019 USD
us-gaap Interest Expense
InterestExpense
21267 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
4537 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
7562 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13019 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-71267 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4537 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7562 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-993159 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1874288 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-474862 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-862311 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
375000 USD
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
-299977 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1250000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-993159 USD
us-gaap Net Income Loss
NetIncomeLoss
-1874288 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-474862 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-862311 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.11
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5545445 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7292737 shares
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5841720 shares
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7541432 shares
CY2013 ltnr Amortization Deferred Stock Based Compensation
AmortizationDeferredStockBasedCompensation
27528 USD
ltnr Amortization Deferred Stock Based Compensation
AmortizationDeferredStockBasedCompensation
20646 USD
CY2013 ltnr Issuance Of Common Shares For Cash
IssuanceOfCommonSharesForCash
200000 USD
CY2013 ltnr Issuance Of Common Shares For Cash Two
IssuanceOfCommonSharesForCashTwo
50000 USD
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
170000 USD
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
100000 USD
CY2013 ltnr Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures One
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeituresOne
-100000 USD
CY2013 ltnr Amortization Of Deferred Director Services
AmortizationOfDeferredDirectorServices
50000 USD
ltnr Amortization Of Deferred Director Services
AmortizationOfDeferredDirectorServices
100000 USD
ltnr Stock Issued During Period Vested Shares Value Forfeited
StockIssuedDuringPeriodVestedSharesValueForfeited
0 USD
ltnr Stock Issued During Period Unvested Shares Value Forfeited
StockIssuedDuringPeriodUnvestedSharesValueForfeited
0 USD
CY2013 ltnr Stock Issued During Period Value Issued For Services One
StockIssuedDuringPeriodValueIssuedForServicesOne
70000 USD
ltnr Stock Issued During Period Value Issued For Services One
StockIssuedDuringPeriodValueIssuedForServicesOne
210000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-1524559 USD
CY2013 ltnr Issuance Of Common Shares For Cash Price Per Share One
IssuanceOfCommonSharesForCashPricePerShareOne
1.00
ltnr Issuance Of Common Shares For Cash Price Per Share One
IssuanceOfCommonSharesForCashPricePerShareOne
1.00
CY2013 ltnr Issuance Of Common Shares For Cash One
IssuanceOfCommonSharesForCashOne
1.00
CY2013 ltnr Stock Issued During Period Price Per Share New Issues
StockIssuedDuringPeriodPricePerShareNewIssues
1.00
CY2013 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
250000 shares
CY2013 ltnr Stock Issued During Period Restricted Stock Award Forfeiture Per Share
StockIssuedDuringPeriodRestrictedStockAwardForfeiturePerShare
1.00
CY2013 ltnr Stock Issued During Period Restricted Stock Award Forfeiture Per Share One
StockIssuedDuringPeriodRestrictedStockAwardForfeiturePerShareOne
1.00
ltnr Stock Issued During Period Vested Shares Forfeited
StockIssuedDuringPeriodVestedSharesForfeited
50000 shares
ltnr Stock Issued During Period Unvested Shares Forfeited
StockIssuedDuringPeriodUnvestedSharesForfeited
50000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
190646 USD
us-gaap Share Based Compensation
ShareBasedCompensation
552729 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5691 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
240939 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24660 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
213828 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13019 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
21267 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
0 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
6 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
250002 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
250002 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-518146 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1026287 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0 USD
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
50000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11424 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2164 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-52164 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
44619 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
23347 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
150000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
575000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1250000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
680381 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1426653 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
150811 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
348202 USD
CY2012Q2 us-gaap Cash
Cash
49689 USD
CY2013Q1 us-gaap Cash
Cash
200500 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Trading Symbol
TradingSymbol
LTNR
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8895000 shares
dei Entity Registrant Name
EntityRegistrantName
LOTON, CORP
dei Entity Central Index Key
EntityCentralIndexKey
0001491419
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2014Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
777784 USD
CY2013Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
527782 USD
CY2013 ltnr Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures Two
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeituresTwo
100000 USD
CY2013 ltnr Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures Three
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeituresThree
-100000 USD
ltnr Stock Issued During Period Value Issued For Services Two
StockIssuedDuringPeriodValueIssuedForServicesTwo
183333 USD
ltnr Stock Issued During Period Value Issued For Services Three
StockIssuedDuringPeriodValueIssuedForServicesThree
38750 USD
CY2013 ltnr Stock Issued During Period Restricted Stock Award Forfeiture Per Share Two
StockIssuedDuringPeriodRestrictedStockAwardForfeiturePerShareTwo
1.00
CY2013 ltnr Stock Issued During Period Restricted Stock Award Forfeiture Per Share Three
StockIssuedDuringPeriodRestrictedStockAwardForfeiturePerShareThree
1.00

Files In Submission

Name View Source Status
0001144204-14-015093-index-headers.html Edgar Link pending
0001144204-14-015093-index.html Edgar Link pending
0001144204-14-015093.txt Edgar Link pending
0001144204-14-015093-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ltnr-20140131.xml Edgar Link completed
ltnr-20140131.xsd Edgar Link pending
ltnr-20140131_cal.xml Edgar Link unprocessable
ltnr-20140131_def.xml Edgar Link unprocessable
ltnr-20140131_lab.xml Edgar Link unprocessable
ltnr-20140131_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v371076_10q.htm Edgar Link pending
v371076_ex31-1.htm Edgar Link pending
v371076_ex31-2.htm Edgar Link pending
v371076_ex32-1.htm Edgar Link pending
v371076_ex32-2.htm Edgar Link pending